ARTICLE | Company News
ExonHit, Allergan deal
January 12, 2009 8:00 AM UTC
The partners extended by two years a 2003 deal to use ExonHit's DATAS gene profiling technology to identify targets in neurodegenerative diseases, pain and ophthalmology. This is the third extension o...